|
⚲
|
| Keyboard |
| Linden Advisors LP
✚
|
|
|---|---|
| CRD # | 135431 |
| SEC # | 801-65641 |
| CIK # | 0001279396 |
| AUM | 38.78 B (2026-03-17) |
| Employees | 48 (52% Investors, 0% Brokers) |
| Phone | 646-840-3500 |
| Address | 590 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Mon, 13 Jul 2026 | SCHMID Group N.V. announced that it has received $19.8 million in funding from Linden Advisors LP, LGT Capital Partners Ltd. — marketscreener.com |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | PCH Manager Fund SPC - Segregated Portfolio 214 | [2019-10-28] | 61.4 M | 946.8 M |
| Filed 2025-08-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Linden Focused Metric Fund Ltd | [2016-02-26] | 1.0 M | |
| Filed 2015-12-02 (D) · Exemption 506(b) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Linden Capital LP | [2012-03-29] | 781.9 M | 37.22 B |
| Filed 2025-08-29 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $3,000,000 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 38.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 38.8 |
| By Discretionary | ||
| Discretionary | 5 | 38.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 38.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 38.8 | |
| United States Persons | 0.0 | |
| Total | 5 | 38.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Michelle Wilson-Clarke | Director | 284 | 70 | |
| John Ackerley | Director | 170 | 70 | |
| Carlos Ferreira | Director | 91 | 36 | |
| James Keyes | Director | 153 | 31 | |
| Roderick Forrest | Executive Officer | 34 | 12 | |
| Vincent Cuticello | Director | 22 | 12 | |
| Nicholas Hoskins | Director | 22 | 9 | |
| Sean Fang | Director | 11 | 9 | |
| Linden Advisors LP | Promoter | 2 | 2 | |
| Saul Ahn | Executive Officer | 2 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001279396] | |
| 3 | [0001279396] | |
| 4 | [0001279396] | |
| SC 13D | [0001279396] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Linden Advisors LP | Tetralogic Pharmaceuticals Corp | [2016-11-14] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.9B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300RZS21MS2DKVC77 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Linden Capital LP | |
| Tetralogic Pharmaceuticals Corp | |
| Linden Advisors LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2024 · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
Preferred Stock · derivative
|
2016-11-14 | Other | |||
|
Tetralogic Pharmaceuticals Corp TLOG
8% Senior Convertible Notes due 2019 · derivative
|
2016-11-14 | Other | 2,095,239 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Ascension Investment Management LLC
✚
|
MO | 40.83 B |
|
Hudson Bay Capital Management LP
✚
|
CT | 40.71 B |
|
Los Angeles Capital Management LLC
✚
|
CA | 40.58 B |
|
Franklin Templeton Investment Management Limited
✚
|
40.52 B | |
|
Blackstone Tactical Opportunities Advisors LLC
✚
|
NY | 40.36 B |
|
IFM Investors US Advisor LLC
✚
|
NY | 40.23 B |
|
Marathon Asset Management Limited
✚
|
39.04 B | |
|
Polar Asset Management Partners Inc
✚
|
37.86 B | |
|
Nomura Corporate Research and Asset Management Inc
✚
|
NY | 37.56 B |
|
Woodline Partners LP
✚
|
CA | 36.66 B |